Clinical benefits and pharmacology of scutellarin: A comprehensive review
The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Abstract Stroke and myocardial infarction are among the most common causes of mortality and disability in the world. The ischemic injury underlying these illnesses is complex, involving intricate interplays among many biological functions including energy metabolism, vascular regulation, hemodynamics, oxidative stress, inflammation, platelet activation, and tissue repair that take place in a context‐ and time‐dependent manner. The current drug therapy of choice is to timely resupply the blood to the ischemic tissue; but reperfusion may introduce additional harm to the tissue through a process known as ischemia/reperfusion injury. As such, new drugs that would complement reperfusion by providing neural and cardiovascular protection and by targeting multiple abnormalities in ischemia are receiving increased attention. Scutellarin is an herbal flavonoid glucuronide with multiple pharmacological activities. Owing to its multiple beneficial effects, such as anti‐oxidant, anti‐inflammation, vascular relaxation, anti‐platelet, anti‐coagulation, and myocardial protection, scutellarin has been used clinically to treat stroke, myocardial infarction, and diabetic complications. Over the past three decades, clinical and pharmacological studies have accumulated a body of evidence that not only demonstrated these therapeutic effects, but also provided significant insights into the pharmacokinetic behavior, therapeutic profile, and mode of action of scutellarin in humans and animal models. Medicinal modification and new drug delivery methods have led to the development of new derivatives and formulations of scutellarin with improved bioavailability, efficacy, and safety. Here we review the current literature on scutellarin to provide a comprehensive understanding of the pharmacological activity, mechanism of action, toxicity, and therapeutic potential of scutellarin for the treatment of ischemia, diabetic complications, and other chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citationOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596 · cited 1×
“Additionally, scutellarin given by i.g. for 7 days decreased the infarct area, neurologic deficit, and cell apoptosis in a dose-dependent manner 24 h after a permanent MCAO injury without reperfusion (Wang et al., 2016).”
BackgroundSelf-citationNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Self-citationEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
Cell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087
Microglia: Scapegoat, saboteur, or something else?
Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836
The Burden of Mortality Attributable to Diabetes
Roglic, G., Unwin, N., Bennett, P. H., Mathers, C., Tuomilehto, J., Nag, S., Connolly, V., & King, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2130 · Cited by 816 · cited 1×
“Diabetes at least doubles a person's risk of early death and about 1.5 to 5.0 million deaths each year result from diabetes (International Diabetes Federation, 2018; Roglic et al., 2005).”
BackgroundInfluentialThe Lifetime Risk of Stroke: Estimates From the Framingham Study
Seshadri, S., Beiser, A., Kelly-Hayes, M., Kase, C. S., Au, R., Kannel, W. B., & Wolf, P. A. (2006) · Stroke · doi:10.1161/01.str.0000199613.38911.b2 · Cited by 705
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.185 · Cited by 477
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Self-citationThe global implications of diabetes and cancer
Shi, Y., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60886-2 · Cited by 424
Antiplatelet therapies for the treatment of cardiovascular disease
Michelson, A. D. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2957 · Cited by 407
Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.33 · Cited by 363
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
Self-citationAkao, T., Kawabata, K., Yanagisawa, E., Ishihara, K., Mizuhara, Y., Wakui, Y., Sakashita, Y., & Kobashi, K. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001777621 · Cited by 252 · cited 1×
“Baicalein is then conjugatedwith glucuronide in the intestinal epithelium and the glucuronide conjugates are secreted into themesenteric blood and the intestinal lumen by transporters MRP3 or MRP2/ BCRP, respectively (Akao et al., 2000; Xing, Chen, and Zhong, 2005; Zhang et al., 2007).”
BackgroundTranscriptional responses to oxidative stress: Pathological and toxicological implications
Ma, Q. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.004 · Cited by 251
Self-citationMitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
Higgins, G. C., & Coughlan, M. T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12503 · Cited by 250
Complications of Diabetes 2016
Papatheodorou, K., Papanas, N., Banach, M., Papazoglou, D., & Edmonds, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6989453 · Cited by 237
Absorption and enterohepatic circulation of baicalin in rats
Xing, J., Chen, X., & Zhong, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.072 · Cited by 230
Liu, X., Cheng, J., Zhang, G., Ding, W., Duan, L., Yang, J., Kui, L., Cheng, X., Ruan, J., Fan, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02883-z · Cited by 224
Papatheodorou, K., Banach, M., Edmonds, M., Papanas, N., & Papazoglou, D. (2015) · Journal of Diabetes Research · doi:10.1155/2015/189525 · Cited by 203
Meta-Analysis of Traditional Chinese Patent Medicine for Ischemic Stroke
Wu, B., Liu, M., Liu, H., Li, W., Tan, S., Zhang, S., & Fang, Y. (2007) · Stroke · doi:10.1161/strokeaha.106.473165 · Cited by 194
Green, A. R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707594 · Cited by 177
Guo, H., Liu, D.-H., Ma, Y., Liu, J.-F., Wang, Y., Du, Z., Wang, X., Shen, J., & Peng, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.150 · Cited by 152
Wu, P.-F., Zhang, Z., Wang, F., & Chen, J.-G. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.186 · Cited by 151
Wang, Z., Yu, J., Wu, J., Feng, Q., Wang, H., Wang, Z., & Xu, Z. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.018 · Cited by 126
Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
Gao, J., Chen, G., He, H., Liu, C., Xiong, X., Li, J., & Wang, J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00289 · Cited by 126
Yuan, Y., Zha, H., Rangarajan, P., Ling, E.-A., & Wu, C. (2014) · BMC Neuroscience · doi:10.1186/s12868-014-0125-3 · Cited by 123
Mechanistic study on the intestinal absorption and disposition of baicalein
Li, Z., Lin, G., Kalapos‐Kovács, B., Jani, M., Krajcsi, P., & Zuo, Z. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.04.001 · Cited by 120
Treating Painful Diabetic Peripheral Neuropathy: An Update.
Snyder, M. J., Gibbs, L. M., & Lindsay, T. J. (2016) · PubMed · Cited by 115
Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation
Wang, S., Wang, H., Guo, H. W., Kang, L., Gao, X., & Hu, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.005 · Cited by 112
Chen, X., Cui, L., Duan, X., Ma, B., & Zhong, D. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009779 · Cited by 109
Pan, Z., Zhao, W., Zhang, X., Wang, B., Wang, J., Sun, X., Liu, X., Feng, S., Yang, B., & Lu, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01070.x · Cited by 107
Neural immunity: Friend or foe?
Gendelman, H. (2002) · Journal of Neurovirology · doi:10.1080/13550280290168631 · Cited by 105
Wang, J., Tan, J., Luo, J., Huang, P., Zhou, W., Chen, L., Long, L., Zhang, L., Zhu, B., Yang, L., et al. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0251-z · Cited by 99
Yuan, Y., Rangarajan, P., Kan, E. M., Wu, Y., Wu, C., & Ling, E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0226-z · Cited by 92
Guo, L., Guan, Z.-Z., Huang, Y., Wang, Y., & Shi, J. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2012.05.003 · Cited by 90
Yu, A. X., Zheng, R.-B., Xie, J., Su, J., Huang, X., Wang, Y., Zheng, Y., Mo, Z., Wu, X., Wu, D.-W., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.12.041 · Cited by 88
Liu, H., Yang, X., Tang, R., Liu, J., & Xu, H. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.09.001 · Cited by 86
Herbal Medicines for Ischemic Stroke: Combating Inflammation as Therapeutic Targets
Gu, Y., Chen, J., & Shen, J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9525-5 · Cited by 86
Zhang, H., Hu, X., Wang, L.-X., Xu, S., & Fan-dian, Z. (2008) · Planta Medica · doi:10.1055/s-0028-1088368 · Cited by 86
Self-citationGuo, H. W., Hu, L., Wang, S., Wang, Y., Shi, F., Li, H., Liu, Y., Kang, L., & Gao, X. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2011.amm059 · Cited by 82
Hu, X., Mi-mei, Z. H. O. U., Hu, X., & Fan-dian, Z. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00239.x · Cited by 81
Tang, H., Tang, Y., Li, N., Shi, Q., Guo, J., Shang, E., & Duan, J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.01.003 · Cited by 81
Campbell, N. R. C., Lackland, D. T., Lisheng, L., Niebylski, M. L., Nilsson, P. M., & Zhang, X. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12479 · Cited by 76
Wang, W., Ma, X., Han, J., Zhou, M., Ren, H., Pan, Q., Zheng, C., & Zheng, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146197 · Cited by 75
Ke, Y., Bao, T., Wu, X., Tang, H., Wang, Y., Ge, J., Fu, B., Xu, M., Chen, L., Zhang, C., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.114 · Cited by 72
Self-citationZhou, H., Chen, X., Chen, L., Zhou, X., Zheng, G., Zhang, H., Huang, W., & Cai, J. (2014) · Molecules · doi:10.3390/molecules191015611 · Cited by 65
Wang, M., Zhang, W.-B., Zhu, J., Fu, G., & Zhou, B. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0164-x · Cited by 61
Chai, L., Guo, H., Li, H., Wang, S., Wang, Y., Shi, F., Hu, L., Liu, Y., & Adah, D. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.011 · Cited by 60
Yuan, Y., Fang, M., Wu, C., & Ling, E. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8394-x · Cited by 56
Guo, C., Zhu, Y., Weng, Y., Wang, S., Guan, Y., Wei, G., Yin, Y., Xi, M., & Wen, A. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.026 · Cited by 52
Li, N., Song, S., Shen, M., Tang, Y., Shi, Z., Tang, H., Shi, Q., Fu, Y., & Duan, J.-A. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.015 · Cited by 51
Xu, X., Zhang, W., Zhang, P., Qi, X., Wu, Y., & Shen, J. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.03.027 · Cited by 49
Protective Effects of Breviscapine on Ischemic Vascular Dementia in Rats
Xiong, Z., Liu, C., Wang, F., Li, C., Wang, W., Wang, J., & Chen, J. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1880 · Cited by 49
Gao, C., Zhang, H., Guo, Z., You, T., Chen, X., & Zhong, D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047183 · Cited by 49
Zhu, J., Choi, R. C. Y., Li, J., Xie, H. Q., Bi, C. W. C., Cheung, A., Dong, T. T.-X., Jiang, Z. Y., Chen, J., & Tsim, K. W. K. (2009) · Planta Medica · doi:10.1055/s-0029-1185776 · Cited by 48
Wei, J., Xie, G., Ge, S., Qiu, Y., Liu, W., Lü, A., Chen, T., Li, H., Zhou, Z., & Jia, W. P. (2011) · Journal of Proteome Research · doi:10.1021/pr2009725 · Cited by 47
Effects of scutellarin on liver function after brain ischemia/reperfusion in rats.
Yang, X., He, W., Lu, W., & Fan-dian, Z. (2003) · PubMed · Cited by 47
Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces
Xing, J., You, H., Dong, Y., Lü, J., Chen, S., Zhu, H.-F., Dong, Q., Wang, M.-Y., & Dong, W. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.11 · Cited by 46
Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation
Han, T., Li, J., Xue, J., Li, H., Xu, F., Cheng, K., Li, D., Li, Z., Gao, M., & Hua, H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.020 · Cited by 45
Gao, R. B., Zhu, B., Tang, S., Wang, J., & Ren, J. T. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00797.x · Cited by 45
Advances in Herbal Medicine for Treatment of Ischemic Brain Injury
Ghosh, N., Ghosh, R., Bhat, Z. A., Mandal, V., Bachar, S. C., Nima, N. D., Sunday, O. O., & Mandal, S. C. (2014) · Natural Product Communications · doi:10.1177/1934578x1400900739 · Cited by 44
Fang, M., Yuan, Y., Rangarajan, P., Lu, J., Wu, Y., Wang, H., Wu, C., & Ling, E. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0219-6 · Cited by 44
He, M., Xue, Z.-M., Li, J., & Zhou, B. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.6 · Cited by 41
Yang, L., Xiao, N., Liu, J., Liu, K., Liu, B., Li, P., & Qi, L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.024 · Cited by 41
Chan, J. Y., Tan, B. K. H., & Lee, S. C. (2009) · PubMed · Cited by 41
Chen, X., Shi, X., Zhang, X., Lei, H., Long, S., Su, H., Pei, Z., & Huang, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/432623 · Cited by 40
Qi, X. M., Wu, G. Z., Wu, Y. G., Lin, H., Shen, J. J., & Shan, L. (2006) · Nephron Experimental Nephrology · doi:10.1159/000094966 · Cited by 40
Anxiolytic-Like Effect of Baicalin and its Additivity with other Anxiolytics
Xu, Z., Wang, F., Tsang, S. Y., Ho, K., Zheng, H., Yuen, C. T., Chow, C., & Xue, H. (2006) · Planta Medica · doi:10.1055/s-2005-873193 · Cited by 39
Wang, W., Lü, L., Bao, T., Zhang, H.-M., Yuan, J., Miao, W., Wang, S., & Xiao, Z. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0660-0 · Cited by 39
Guo, L., Guan, Z., & Wang, Y.-L. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.115 · Cited by 38
Tian, X., Chang, L., Ma, G., Wang, T., Lv, M., Wang, Z., Chen, L., Wang, Y., Gao, X., & Zhu, Y. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00511 · Cited by 37
Liu, X., Yao, L., Sun, D., Zhu, X., Liu, Q., Xu, T., & Wang, L. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3483 · Cited by 33
Self-citationZheng, C., Ou, W., Shen, H., Zhou, Z., & Wang, J. (2015) · BioMed Research International · doi:10.1155/2015/680756 · Cited by 28
Wu, C., Fang, M., Karthikeyan, A., Yuan, Y., & Ling, E. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666161118142045 · Cited by 28
Xiong, F., Chen, X., Yao, J., Chen, X., & Gu, N. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.10.008 · Cited by 25
Wang, C., Li, Y., Gao, S., Cheng, D., Zhao, S., & Liu, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129969 · Cited by 24
Tang, H., Tang, Y., Li, N., Lin, H., Li, W., Shi, Q., Zhang, W. K., Zhang, P., Dong, Z., Shen, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131569 · Cited by 24
Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-Iα
Li, L., Li, L., Chen, C., Yang, J., Li, J., Hu, N., Li, Y., Zhang, D., Guo, T., Liu, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139570 · Cited by 23 · cited 1×
“The protective effect of scutellarin against myocardial I/R injury was demonstrated in a separate study (Li et al., 2015).”
BackgroundWu, Y., Fan, Q., Lu, N., Tao, L., Gao, Y., Qi, Q., & Guo, Q. (2010) · Phytotherapy Research · doi:10.1002/ptr.3002 · Cited by 22
Han, Y., Li, D., Yang, Q., Zhou, Z.-Y., Liu, L., Li, B., Lu, J., & Guo, C. (2014) · Molecules · doi:10.3390/molecules19055748 · Cited by 19
Mrp2-related efflux of scutellarin in the intestinal absorption in rats
Cao, F., Zhang, H., Guo, J., & Ping, Q. (2008) · Die Pharmazie · doi:10.31083/ph.2008.7636 · Cited by 16
Protective effect of 6-O-methyl-scutellarein on repeated cerebral ischemia/reperfusion in rats
Wu, W., Zhong, Y., Lu, Y., Sun, Y. J., Li, N., Shi, Z., Dong, Z., Gu, T., Xue, X., Fang, F., et al. (2017) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2017.1383396 · Cited by 7
Cited by
Peng, L., Wen, L., Shi, Q.-F., Gao, F., Huang, B., Meng, J., Hu, C.-P., & Wang, C.-M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03178-2 · Cited by 385
Pratyusha, D. S., & Sarada, D. V. L. (2022) · Plant Cell Reports · doi:10.1007/s00299-022-02927-1 · Cited by 221
Metadata
- Authors
- Wang, L., & Ma, Q.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 190
- Pages
- 105-127
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2800060797
- Cited by
- 229
- References
- 92
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.